Related Experiment Video

Updated: Aug 15, 2026

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on: October 17, 2025

BIRB-796 is not an effective ABL(T315I) inhibitor

Thomas O'Hare, Brian J Druker

    Nature Biotechnology
    |October 8, 2005
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Assays for the Identification of Novel Antivirals against Bluetongue Virus12:02

    Assays for the Identification of Novel Antivirals against Bluetongue Virus

    Published on: October 11, 2013

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...